Antihistamine use and immunoglobulin E levels in glioma risk and prognosis

Cancer Epidemiology

Volumn 37, Issue 6, 2013, Pages 908-912

  Amirian, E Susan ^a   Marquez Do, Deborah ^a   Bondy, Melissa L ^a   Scheurer, Michael E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Brain neoplasms; Case control studies; Epidemiology; Hypersensitivity; Immunoglobulin E; Risk factors; Survival

Indexed keywords

ANTIHISTAMINIC AGENT; IMMUNOGLOBULIN E;

ADULT; ALLERGY; ARTICLE; ASTHMA; CANCER PROGNOSIS; CANCER RISK; CHICKENPOX; CONTROLLED STUDY; FEMALE; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; PRIORITY JOURNAL;

BRAIN NEOPLASMS; CASE-CONTROL STUDIES; EPIDEMIOLOGY; HYPERSENSITIVITY; IMMUNOGLOBULIN E; RISK FACTORS; SURVIVAL;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HISTAMINE ANTAGONISTS; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 84888293354     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.08.004     Document Type: Article

References (46)

1. Fisher J.L., Schwartzbaum J.A., Wrensch M., Wiemels J.L. Epidemiology of brain tumors. Neurol Clin 2007, 25(4):867-890. vii.
2. Schwartzbaum J.A., Fisher J.L., Aldape K.D., Wrensch M. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2006, 2(9):494-503.
3. Schwartzbaum J.A., Huang K., Lawler S., Ding B., Yu J., Chiocca E.A. Allergy and inflammatory transcriptome is predominantly negatively correlated with CD133 expression in glioblastoma. Neuro-Oncology 2010, 12(4):320-327.
4. Backes D.M., Siddiq A., Cox D.G., Calboli F.C., Gaziano J.M., Ma J., et al. Single-nucleotide polymorphisms of allergy-related genes and risk of adult glioma. J Neurooncol 2013.
5. Schwartzbaum J.A., Xiao Y., Liu Y., Tsavachidis S., Berger M.S., Bondy M.L., et al. Inherited variation in immune genes and pathways and glioblastoma risk. Carcinogenesis 2010, 31(10):1770-1777.
6. Davis F.G., Al-Alem U. Allergies and adult gliomas: cohort results strengthen evidence for a causal association. J Natl Cancer Inst 2011, 103(21):1562-1563.
7. Calboli F.C., Cox D.G., Buring J.E., Gaziano J.M., Ma J., Stampfer M., et al. Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies. J Natl Cancer Inst 2011, 103(21):1588-1595.
8. Wiemels J.L., Wiencke J.K., Kelsey K.T., Moghadassi M., Rice T., Urayama K.Y., et al. Allergy-related polymorphisms influence glioma status and serum IgE levels. Cancer Epidemiol Biomarkers Prev 2007, 16(6):1229-1235.
9. Brenner A.V., Butler M.A., Wang S.S., Ruder A.M., Rothman N., Schulte P.A., et al. Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma. Carcinogenesis 2007, 28(12):2543-2547.
10. Amirian E., Liu Y., Scheurer M.E., El-Zein R., Gilbert M.R., Bondy M.L. Genetic variants in inflammation pathway genes and asthma in glioma susceptibility. Neuro-Oncology 2010, 12(5):444-452.
11. Scheurer M.E., El-Zein R., Thompson P.A., Aldape K.D., Levin V.A., Gilbert M.R., et al. Long-term anti-inflammatory and antihistamine medication use and adult glioma risk. Cancer Epidemiol Biomarkers Prev 2008, 17(5):1277-1281.
12. Scheurer M.E., Amirian E.S., Davlin S.L., Rice T., Wrensch M., Bondy M.L. Effects of antihistamine and anti-inflammatory medication use on risk of specific glioma histologies. Int J Cancer 2011, 129(9):2290-2296.
13. Schwartzbaum J., Ding B., Johannesen T.B., Osnes L.T., Karavodin L., Ahlbom A., et al. Association between prediagnostic IgE levels and risk of glioma. J Natl Cancer Inst 2012, 104(16):1251-1259.
14. Wiemels J.L., Wrensch M., Sison J.D., Zhou M., Bondy M., Calvocoressi L., et al. Reduced allergy and immunoglobulin E among adults with intracranial meningioma compared to controls. Int J Cancer 2011, 129(8):1932-1939.
15. Lachance D.H., Yang P., Johnson D.R., Decker P.A., Kollmeyer T.M., McCoy L.S., et al. Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking. Am J Epidemiol 2011, 174(5):574-581.
16. Turner M.C., Krewski D., Armstrong B.K., Chetrit A., Giles G.G., Hours M., et al. Allergy and brain tumors in the INTERPHONE study: pooled results from Australia, Canada, France, Israel, and New Zealand. Cancer Causes Control 2013, 24(5):949-960.
17. Wiemels J.L., Wilson D., Patil C., Patoka J., McCoy L., Rice T., et al. IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era. Int J Cancer 2009, 125(3):680-687.
18. Zhou M., Wiemels J.L., Bracci P.M., Wrensch M.R., McCoy L.S., Rice T., et al. Circulating levels of the innate and humoral immune regulators CD14 and CD23 are associated with adult glioma. Cancer Res 2010, 70(19):7534-7542.
19. Schlehofer B., Siegmund B., Linseisen J., Schuz J., Rohrmann S., Becker S., et al. Primary brain tumours and specific serum immunoglobulin E: a case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohort. Allergy 2011, 66(11):1434-1441.
20. Linos E., Raine T., Alonso A., Michaud D. Atopy and risk of brain tumors: a meta-analysis. J Natl Cancer Inst 2007, 99(20):1544-1550.
21. Brandes L.J., Warrington R.C., Arron R.J., Bogdanovic R.P., Fang W., Queen G.M., et al. Enhanced cancer growth in mice administered daily human-equivalent doses of some H1-antihistamines: predictive in vitro correlates. J Natl Cancer Inst 1994, 86(10):770-775.
22. Erber E., Lim U., Maskarinec G., Kolonel L.N. Common immune-related risk factors and incident non-Hodgkin lymphoma: the multiethnic cohort. Int J Cancer 2009, 125(6):1440-1445.
23. Kelly J.P., Rosenberg L., Palmer J.R., Rao R.S., Strom B.L., Stolley P.D., et al. Risk of breast cancer according to use of antidepressants, phenothiazines, and antihistamines. Am J Epidemiol 1999, 150(8):861-868.
24. McCredie M., Maisonneuve P., Boyle P. Antenatal risk factors for malignant brain tumours in New South Wales children. Int J Cancer 1994, 56(1):6-10.
25. McKean-Cowdin R., Pogoda J.M., Lijinsky W., Holly E.A., Mueller B.A., Preston-Martin S. Maternal prenatal exposure to nitrosatable drugs and childhood brain tumours. Int J Epidemiol 2003, 32(2):211-217.
26. Nadalin V., Cotterchio M., Kreiger N. Antihistamine use and breast cancer risk. Int J Cancer 2003, 106(4):566-568.
27. Selby J.V., Friedman G.D., Fireman B.H. Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up. Cancer Res 1989, 49(20):5736-5747.
28. McCarthy B.J., Rankin K., Il'yasova D., Erdal S., Vick N., Ali-Osman F., et al. Assessment of type of allergy and antihistamine use in the development of glioma. Cancer Epidemiol Biomarkers Prev 2011, 20(2):370-378.
29. Harlow B.L., Davis S. Two one-step methods for household screening and interviewing using random digit dialing. Am J Epidemiol 1988, 127(4):857-863.
30. Hartge P., Brinton L.A., Rosenthal J.F., Cahill J.I., Hoover R.N., Waksberg J. Random digit dialing in selecting a population-based control group. Am J Epidemiol 1984, 120(6):825-833.
31. Dubrow R., Darefsky A.S. Demographic variation in incidence of adult glioma by subtype, United States, 1992-2007. BMC Cancer 2011, 11:325.
32. Wrensch M., Weinberg A., Wiencke J., Masters H., Miike R., Barger G., et al. Does prior infection with varicella-zoster virus influence risk of adult glioma?. Am J Epidemiol 1997, 145(7):594-597.
33. Wrensch M., Weinberg A., Wiencke J., Miike R., Barger G., Kelsey K. Prevalence of antibodies to four herpesviruses among adults with glioma and controls. Am J Epidemiol 2001, 154(2):161-165.
34. Wrensch M., Weinberg A., Wiencke J., Miike R., Sison J., Wiemels J., et al. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls. Am J Epidemiol 2005, 161(10):929-938.
35. Sjostrom S., Hjalmars U., Juto P., Wadell G., Hallmans G., Tjonneland A., et al. Human immunoglobulin G levels of viruses and associated glioma risk. Cancer Causes Control 2011, 22(9):1259-1266.
36. Silverberg J.I., Kleiman E., Silverberg N.B., Durkin H.G., Joks R., Smith-Norowitz T.A. Chickenpox in childhood is associated with decreased atopic disorders, IgE, allergic sensitization, and leukocyte subsets. Pediatr Allergy Immunol 2012, 23(1):50-58.
37. Silverberg J.I., Norowitz K.B., Kleiman E., Silverberg N.B., Durkin H.G., Joks R., et al. Association between varicella zoster virus infection and atopic dermatitis in early and late childhood: a case-control study. J Allergy Clin Immunol 2010, 126(2):300-305.
38. Wigertz A., Lonn S., Schwartzbaum J., Hall P., Auvinen A., Christensen H.C., et al. Allergic conditions and brain tumor risk. Am J Epidemiol 2007, 166(8):941-950.
39. Carosso A., Bugiani M., Migliore E., Anto J.M., DeMarco R. Reference values of total serum IgE and their significance in the diagnosis of allergy in young European adults. Int Arch Allergy Immunol 2007, 142(3):230-238.
40. Hoppin J.A., Jaramillo R., Salo P., Sandler D.P., London S.J., Zeldin D.C. Questionnaire predictors of atopy in a US population sample: findings from the National Health and Nutrition Examination Survey, 2005-2006. Am J Epidemiol 2011, 173(5):544-552.
41. Suh J.D., Kennedy D.W. Treatment options for chronic rhinosinusitis. Proc Am Thorac Soc 2011, 8(1):132-140.
42. Cianchi F., Vinci M.C., Masini E. Histamine in cancer: the dual faces of the coin. Cancer Biol Ther 2008, 7(1):36-37.
43. Medina M.A., Quesada A.R., Nunez de Castro I., Sanchez-Jimenez F. Histamine, polyamines, and cancer. Biochem Pharmacol 1999, 57(12):1341-1344.
44. Medina V.A., Rivera E.S. Histamine receptors and cancer pharmacology. Br J Pharmacol 2010, 161(4):755-767.
45. Agarwala S.S., Sabbagh M.H. Histamine dihydrochloride: inhibiting oxidants and synergising IL-2-mediated immune activation in the tumour microenvironment. Expert Opin Biol Ther 2001, 1(5):869-879.
46. Hellstrand K., Hansson M., Hermodsson S. Adjuvant histamine in cancer immunotherapy. Semin Cancer Biol 2000, 10(1):29-39.